Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2020 3
2021 7
2022 12
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial.
Mazighi M, Richard S, Lapergue B, Sibon I, Gory B, Berge J, Consoli A, Labreuche J, Olivot JM, Broderick J, Duhamel A, Touze E, Qureshi AI, Yavchitz A, Escalard S, Desilles JP, Redjem H, Smajda S, Fahed R, Hébert S, Maïer B, Delvoye F, Boursin P, Maacha MB, Obadia M, Sabben C, Blanc R, Savatovsky J, Piotin M; BP-TARGET investigators. Mazighi M, et al. Lancet Neurol. 2021 Apr;20(4):265-274. doi: 10.1016/S1474-4422(20)30483-X. Epub 2021 Feb 26. Lancet Neurol. 2021. PMID: 33647246 Clinical Trial.
Heterozygous HTRA1 nonsense or frameshift mutations are pathogenic.
Coste T, Hervé D, Neau JP, Jouvent E, Ba F, Bergametti F, Lamy M, Cogez J, Derache N, Schneckenburger R, Grelet M, Gollion C, Lanotte L, Lauer V, Layet V, Urbanczyk C, Didic M, Raynouard I, Delaval L, Dassa J, Florea A, Badiu C, Nguyen K, Tournier-Lasserve E. Coste T, et al. Among authors: raynouard i. Brain. 2021 Oct 22;144(9):2616-2624. doi: 10.1093/brain/awab271. Brain. 2021. PMID: 34270682
Effect of blood pressure variability in the randomized controlled BP TARGET trial.
Maïer B, Gory B, Lapergue B, Sibon I, Escalard S, Kyheng M, Labreuche J, de Havenon A, Petersen N, Anadani M, Gayat E, Boursin P, Ben Maacha M, Desilles JP, Blanc R, Piotin M, Halimi JM, Mazighi M; BP TARGET Investigators. Maïer B, et al. Eur J Neurol. 2022 Mar;29(3):771-781. doi: 10.1111/ene.15194. Epub 2021 Dec 17. Eur J Neurol. 2022. PMID: 34821437 Clinical Trial.
Magnitude of Blood Pressure Change After Endovascular Therapy and Outcomes: Insight From the BP-TARGET Trial.
Anadani M, Maïer B, Escalard S, Labreuche J, de Havenon A, Sabben C, Lapergue B, Gory B, Richard S, Sibon I, Desilles JP, Blanc R, Piotin M, Mazighi M; of behalf the BP-TARGET Study Group*. Anadani M, et al. Stroke. 2022 Mar;53(3):719-727. doi: 10.1161/STROKEAHA.121.036701. Epub 2022 Feb 3. Stroke. 2022. PMID: 35109685 Free article. Clinical Trial.
Endovascular treatment of ischemic stroke due to isolated internal carotid artery occlusion: ETIS registry data analysis.
Ter Schiphorst A, Peres R, Dargazanli C, Blanc R, Gory B, Richard S, Marnat G, Sibon I, Guillon B, Bourcier R, Denier C, Spelle L, Labreuche J, Consoli A, Lapergue B, Costalat V, Obadia M, Arquizan C; ETIS Registry Investigators. Ter Schiphorst A, et al. J Neurol. 2022 Aug;269(8):4383-4395. doi: 10.1007/s00415-022-11078-y. Epub 2022 Mar 31. J Neurol. 2022. PMID: 35357557
Endovascular reperfusion of M2 occlusions in acute ischemic stroke reduced disability and mortality: ETIS Registry results.
Muszynski P, Anadani M, Richard S, Marnat G, Bourcier R, Sibon I, Dargazanli C, Arquizan C, Maïer B, Blanc R, Lapergue B, Consoli A, Eugene F, Vannier S, Spelle L, Denier C, Boulanger M, Gauberti M, Saleme S, Macian F, Clarençon F, Rosso C, Naggara O, Turc G, Ozkul-Wermester O, Papagiannaki C, Viguier A, Cognard C, Le Bras A, Evain S, Wolff V, Pop R, Timsit S, Gentric JC, Bourdain F, Veunac L, Gory B, Finitsis SN; ETIS Registry Investigators. Muszynski P, et al. J Neurointerv Surg. 2022 May;14(5):neurintsurg-2021-017380. doi: 10.1136/neurintsurg-2021-017380. Epub 2021 May 27. J Neurointerv Surg. 2022. PMID: 34045317
Demyelinating polyradiculoneuritis in patients with multiple myeloma: the other side of bortezomib-induced neurotoxicity.
Gendreau S, Berzero G, Tafani C, Raynouard I, Ricard D, Malfuson JV, Viala K, Debs R, Houillier C, Diamanti L, Marchioni E, Lenglet T, Ouzegdouh M, Bihan K, Gilardin L, Psimaras D. Gendreau S, et al. Among authors: raynouard i. Acta Oncol. 2020 Apr;59(4):484-489. doi: 10.1080/0284186X.2020.1723163. Epub 2020 Mar 3. Acta Oncol. 2020. PMID: 32122210 No abstract available.
Collateral status reperfusion and outcomes after endovascular therapy: insight from the Endovascular Treatment in Ischemic Stroke (ETIS) Registry.
Anadani M, Finitsis S, Clarençon F, Richard S, Marnat G, Bourcier R, Sibon I, Dargazanli C, Arquizan C, Blanc R, Lapergue B, Consoli A, Eugene F, Vannier S, Spelle L, Denier C, Boulanger M, Gauberti M, Liebeskind DS, de Havenon A, Saleme S, Macian F, Rosso C, Naggara O, Turc G, Ozkul-Wermester O, Papagiannaki C, Viguier A, Cognard C, Le Bras A, Evain S, Wolff V, Pop R, Timsit S, Gentric JC, Bourdain F, Veunac L, Maier B, Gory B; ETIS Registry Investigators. Anadani M, et al. J Neurointerv Surg. 2022 Jun;14(6):551-557. doi: 10.1136/neurintsurg-2021-017553. Epub 2021 Jun 17. J Neurointerv Surg. 2022. PMID: 34140288
24 results